Anti-PAD2 monoclonal antibody - Pharma Foods International
Alternative Names: Anti-PAD2 mAb - Pharma Foods InternationalLatest Information Update: 28 Aug 2024
At a glance
- Originator Pharma Foods International
- Class Monoclonal antibodies
- Mechanism of Action Protein-arginine deiminase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for research development in Autoimmune-disorders in Japan (Parenteral)
- 22 Jul 2020 Early research in Autoimmune disorders in Japan (Parenteral) (Pharma Foods International pipeline, July 2020)